18-10704450-A-G

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_001378183.1(PIEZO2):​c.6202T>C​(p.Leu2068Leu) variant causes a synonymous change. The variant allele was found at a frequency of 0.00138 in 1,537,226 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0072 ( 20 hom., cov: 33)
Exomes 𝑓: 0.00074 ( 13 hom. )

Consequence

PIEZO2
NM_001378183.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 3.87

Publications

0 publications found
Variant links:
Genes affected
PIEZO2 (HGNC:26270): (piezo type mechanosensitive ion channel component 2) The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]
PIEZO2 Gene-Disease associations (from GenCC):
  • Gordon syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • arthrogryposis, distal, with impaired proprioception and touch
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics
  • arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • connective tissue disorder
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • Marden-Walker syndrome
    Inheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 18-10704450-A-G is Benign according to our data. Variant chr18-10704450-A-G is described in ClinVar as Benign. ClinVar VariationId is 783798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00725 (1104/152286) while in subpopulation AFR AF = 0.0238 (988/41552). AF 95% confidence interval is 0.0225. There are 20 homozygotes in GnomAd4. There are 524 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378183.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PIEZO2
NM_001378183.1
MANE Select
c.6202T>Cp.Leu2068Leu
synonymous
Exon 42 of 56NP_001365112.1
PIEZO2
NM_001410871.1
c.5938T>Cp.Leu1980Leu
synonymous
Exon 40 of 54NP_001397800.1
PIEZO2
NM_022068.4
c.5863T>Cp.Leu1955Leu
synonymous
Exon 38 of 52NP_071351.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PIEZO2
ENST00000674853.1
MANE Select
c.6202T>Cp.Leu2068Leu
synonymous
Exon 42 of 56ENSP00000501957.1
PIEZO2
ENST00000503781.7
TSL:1
c.5863T>Cp.Leu1955Leu
synonymous
Exon 38 of 52ENSP00000421377.3
PIEZO2
ENST00000580640.5
TSL:5
c.5938T>Cp.Leu1980Leu
synonymous
Exon 40 of 54ENSP00000463094.1

Frequencies

GnomAD3 genomes
AF:
0.00723
AC:
1100
AN:
152168
Hom.:
20
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0238
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00595
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00812
GnomAD2 exomes
AF:
0.00168
AC:
238
AN:
141888
AF XY:
0.00116
show subpopulations
Gnomad AFR exome
AF:
0.0265
Gnomad AMR exome
AF:
0.00118
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000514
Gnomad OTH exome
AF:
0.000711
GnomAD4 exome
AF:
0.000739
AC:
1024
AN:
1384940
Hom.:
13
Cov.:
30
AF XY:
0.000604
AC XY:
413
AN XY:
683400
show subpopulations
African (AFR)
AF:
0.0235
AC:
743
AN:
31592
American (AMR)
AF:
0.00216
AC:
77
AN:
35700
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25182
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35734
South Asian (SAS)
AF:
0.0000379
AC:
3
AN:
79236
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35000
Middle Eastern (MID)
AF:
0.00176
AC:
10
AN:
5696
European-Non Finnish (NFE)
AF:
0.0000686
AC:
74
AN:
1078886
Other (OTH)
AF:
0.00202
AC:
117
AN:
57914
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
65
130
194
259
324
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00725
AC:
1104
AN:
152286
Hom.:
20
Cov.:
33
AF XY:
0.00704
AC XY:
524
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0238
AC:
988
AN:
41552
American (AMR)
AF:
0.00595
AC:
91
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68022
Other (OTH)
AF:
0.00803
AC:
17
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
56
112
169
225
281
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00269
Hom.:
2
Bravo
AF:
0.00817
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
8.7
DANN
Benign
0.79
PhyloP100
3.9
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112982077; hg19: chr18-10704448; API